|
|
NORTHWESTERN MEDICINE EXPERTS AT DDW 2025
The Northwestern Medicine Digestive Health Center brings together some of the best academic and clinical minds in pursuit of medical excellence in gastrointestinal health. Our mission is to prevent, diagnose and treat disorders of the digestive tract and associated organs.
At the heart of our success is an integrated approach through multidisciplinary clinical teams who work to bring top-quality care to patients from around the world. Each multidisciplinary clinical team includes internationally renowned gastroenterologists, interventional endoscopists, surgeons, psychologists and dietitians. We work with patients to control the symptoms that negatively affect their health and lives while focusing on the treatment of their condition or disease.
At the heart of our success is an integrated approach through multidisciplinary clinical teams who work to bring top-quality care to patients from around the world. Each multidisciplinary clinical team includes internationally renowned gastroenterologists, interventional endoscopists, surgeons, psychologists and dietitians. We work with patients to control the symptoms that negatively affect their health and lives while focusing on the treatment of their condition or disease.
MEET SOME OF THE NORTHWESTERN MEDICINE PRESENTERS
Monday, May 5 at 2:00 pm PST
Plenary Session 0001 | Presentation of Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Research Mentor Award: Stephen Hanauer, MD, AGAF Featuring: Stephen Hanauer, MD |
Sunday, May 4 at 12:30 – 1:30 pm PST
Mixed-Methods Approach and Endoscopic Skill Sharing for the Improvement of Bedside Dobhoff Tube Placement Among Non-Endoscopists Featuring: Justin Boike, MD with Rajesh Keswani, MD and trainee Vasilios Kalas, MD, PhD |
Monday, May 5 at 4:00 – 5:30 pm PST
Session 4560 | Biliary Battles: Hot Topics and Heated Opinions in ERCP Featuring: Jasmine Sinha, MD |
Sunday, May 4 at 12:30 – 1:30 pm PST
A Clear Difference: Optimizing a Successful Inpatient Colonoscopy Order Set to Decrease Repeat or Cancelled Procedures Featuring: Rajesh Keswani, MD with Justin Boike, MD |
Tuesday, May 6 at 12:30 – 1:30 pm PST
Unraveling The Impact of Diabetes and Glycemic Control in the Development of Pancreatic Adenocarcinoma: Insights From a Large Healthcare System Featuring: Srinadh Komanduri, MD with trainee Kevin Shah |
Sunday, May 4 at 2:54 pm PST
IBS: FDA Approved Medications Versus Neuromodulation Featuring: Darren Brenner, MD |
|
Date & Time
All times in PST
|
Session
|
Presenter
|
|
Saturday, May 3
12:30 - 1:30 pm |
Artificial Intelligence Showdown: Comparison of Large Language Models in the Diagnosis and Management of Gastrointestinal Conditions
|
|
Saturday, May 3
12:30 - 1:30 pm |
Artificial Intelligence Showdown: Comparison of Large Language Models in the Diagnosis and Management of Gastrointestinal Conditions
|
Srinadh Komanduri, MD
Trainees Shravya Pothula and Kevin Shah |
|
Sunday, May 4
10:00 – 11:30 am |
Session #3200
IMIBD_CS_02: Farron and Martin Brotman, MD, Lecture — IBD in 2025: Reviewing a Quarter Century of Progress |
Stephen Hanauer, MD (Moderator)
|
|
Sunday, May 4
12:30 – 1:30 pm |
A Clear Difference: Optimizing a Successful Inpatient Colonoscopy Order Set to Decrease Repeat or Cancelled Procedures
|
|
Sunday, May 4
12:30 – 1:30 pm |
Risk Of Development Of Barrett’s Esophagus and Esophageal Adenocarcinoma Increases With Severity of Obesity
|
|
Sunday, May 4
12:30 – 1:30 pm |
Mixed-Methods Approach and Endoscopic Skill Sharing for the Improvement of Bedside Dobhoff Tube Placement Among Non-Endoscopists
|
|
Sunday, May 4
2:54 pm |
IBS: FDA Approved Medications Versus Neuromodulation
|
|
Monday, May 5
12:30 – 1:30 pm |
The Impact of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Use on Gastroesophageal Reflux and the Development of Esophageal Adenocarcinoma
|
|
Monday, May 5
2:00 pm |
Plenary Session 0001
Presentation of Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Research Mentor Award: Stephen Hanauer, MD, AGAF |
|
Monday, May 5
4:00 – 5:30 pm |
Session 4560
Biliary Battles: Hot Topics and Heated Opinions in ERCP |
|
Tuesday, May 6
8:00 – 9:30 am |
Session 5150
Validation of FLIP Panometry Classification for Esophageal Motility v2.0 in 558 Patients: Comparison with High-Resolution Manometry and FLIP v1.0 |
Dustin Carlson, MD (Moderator)
Trainee Ofer Fass |
|
Tuesday, May 6
12:30 – 1:30 pm |
Unraveling The Impact of Diabetes and Glycemic Control in the Development of Pancreatic Adenocarcinoma: Insights From a Large Healthcare System
|
|
Date & Time TBA
|
Neither Tenapanor nor its Major Metabolite Were Detected in the Breast Milk Of Healthy Lactating Females After 4 Days of Dosing: A Phase 1, Open-Label, Pharmacokinetic
|
Follow Northwestern Medicine Gastroenterology
|
|
|
|